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ABSTRACT
Neurological disorders are the impairments of nervous system and are an important and growing cause of morbidity,
mortality, and disability. In addition to health costs, those suffering from these conditions are also frequently
victimized of stigmatization and discrimination. Stigmatization further minimizes the patients' access to treatment
and social activities. These disorders, therefore, require special attention particularly in developing countries where
unfortunately, the burden of these disorders remains largely unrecognized. Moreover, the burden imposed by such
chronic neurological conditions in general can be expected to be particularly devastating in poor populations. These
conditions are emerging as severe public health concerns in the developing countries due to the facts such as
unawareness, Illiteracy, large numbers of people who are untreated, and unavailability of inexpensive but effective
interventions. Regrettably, reliable population-based data from developing countries including Pakistan on the
epidemiology of neurological disorders are extremely limited. Although, some information on epidemiological
aspects of neurological diseases are available from some developing countries (Pakistan, Iran, India, Sri Lanka,
Saudi Arabia and China) but disease prevalence and pattern are based on geographical, social, cultural, religious,
and ethnic factors. In this review, w e critically analyzed data of 209 studies regarding the burden and prevalence of
hypertension, depression, Stroke, Alzheimer's disease (AD), epilepsy, and Parkinson's disease (PD) in Pakistan and
neighboring countries.
Stroke, Cerebral Palsy (CP), Mental Retardation (MR)
developmental disorders, peripheral neuropathy and
Migraine are the well-known parallels of NDs around
the world3,4. The manifestations of NDs are also
accompanied by malfunctioning of another
physiological system including dyslipidemia,
enhanced metabolic rate and diabetes mellitus57.
These disorders are among the most compelling
maladies known to humankind that is typically
devastating to the affected one sand their families. The
conventional methods are unable to elucidate the
mechanism of the pathophysiology of these disorders
due to the involvement of brain in live patients8.
Therefore, majority of NDs are currently without
effective therapies and life quality can be maintained
only by management approaches such as
supplementation of high fat diet and chronic exercise
offer beneﬁcial effects in case of neurodegenerative
disorders6,912.
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Epidemiological data play a vital role in portraying the disease patterns and occurrence in the community. However,
the published data on the estimation of the burden and spectrum of major NDs in Pakistan is very scanty. The burden
of NDs in Pakistan is supposed to be enormous due to several causative factors in this country such as hypertension,
poor hygienic conditions, adulterated edible stuff, poverty, illiteracy, high prevalence of diabetes mellitus and
cardiovascular disorders. Pakistan is predicted to be at the 4th place in term of diabetes mellitus prevalence (one of
the important risk factor of NDs) in 202013. Presently, one-third of the population above the age of 45 years is
hypertensive14. Most importantly, the majority of the population is unaware of their status of Nds. The prevalence data
for most of the NDs in Pakistan is very scarce due to lack of interest in epidemiological studies. Most of the available
data is hospital-based estimations or physicians collected data of their respective regions10,1517. These data may not
be considered as a representative of the whole nation but available data still can be used to compare it with other
countries. So, it is necessary to conduct epidemiological studies to get reliable data on prevalence that can be used
to assess the actual burden of NDs in Pakistan.
In this review, we have organized and compared the available data of NDs in Pakistan with the data of Iran, China,
India, and Saudi Arabia (Table 1). This effort covers the prevalence and comparison of NDs including hypertension,
stroke, epilepsy, depression, Parkinson's disease (PD) and Alzheimer's disease (AD) in the above mentioned
countries. This is an attempt to evaluate the burden of NDs in Pakistan and a comparison with the neighboring
counties.

METHODS OF LITERATURE SEARCH
A total of 209 original research and review articles were
found by use of NCBI-PubMed and Google search
engine. Since most of the studies are found on the
websites of local journals of the selected countries,
therefore, varying key words for each disorder were
used to ﬁnd the articles containing required
information.
OVERVIEW OF THE WORLDWIDE PREVALENCE
OF NEUROLOGICAL DISORDERS
These disorder shave been the most neglected class
of diseases around the world. A number of deaths
resulted by any disease have been considered as the
seriousness of a disease in the last decades. They
deviate this obsolete criterion and demise is not the
acute fate of the affected ones but sufferings may last
throughout the life. The care givers and family
members also confront these issues along with the
patients18,19 . The overall number of deaths and
disabilities caused by NDs is higher than any other
disorder all over the world4,10,11,2023.The worldwide
burden of NDs is increasing unchecked at an alarming
rate with a prevalence of 6.5%. Presently, the burden
appears to be strongly correlated to the economic
condition of that particular country as the global burden
of NDs in high, upper middle, lower middle and low
income countries is10.9%, 6.7%, 8.7% and
4.5%,respectively2,10,11,18,2227. This high rate of NDs in the
developed countries is advocated by the increased
provision of health related facilities and reliable data
source4,22,2729
The epidemiological data of NDs in the developed
countries is well documented. For example, in the
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USA,6.75% population orone in every 15 individuals
has some neurological condition30.The prevalence of
NDs in the UK is 6% andamong those,
cerebrovascular disorders, shingle, and diabetic
polyneuropathies are the most commonly reported
diseases31.
In the developing countries, NDs are among the
ignored class of disorders and mostly they are not
considered as diseases due to illiteracy and
superstitious thoughts. Therefore, developing
countries lack the basic epidemiological data
regarding NDs prevalence. In addition, there is an
uncertainty in the available data due to very few
studies and unreliable methodologies for the collection
of data. Pakistan is among those developing countries
of Asia where very few epidemiological studies have
been conducted regarding the prevalence and burden
of various disorders, particularly NDs3,4,22,3234.
About 60% of the world's population resides in
Asia,while China, India, Pakistan, and Iran are the
habitats of about 65% of thisAsian population.
Although, the data for NDs are available for some
developing countries of Asia but these data mostly
comprise of comparison among various geographical,
social, cultural, religious, and ethnic groups. Based on
available data, it could be assumed that the prevalence
and incidence of NDs are increasing in the developing
countries of Asia. Factors causing this upsurge in the
burden of NDs may include increasing life expectancy,
literacy, urbanization, and provision of better
diagnostic and medical facilities 10,20,21,3537.
In China, the most populated country in the world with
1.367 billion dwellers, the burden of NDs is not uniform
throughout the country. Between 2013 and 2025, the
burden of mental, neurological and substance use
disorders is estimated to increase by 10% in China36,37.
P r e s e n t l y, t h e m o s t c o m m o n N d s a r e
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cerebrovascular diseases with the prevalence of
22.39%. The others include mild cognitive impairment
and dementia that account 15.99%, movement
disorders (including Parkinson's disease) with 9.09%
prevalence; sleep disorders (including sleep apnea
and insomnia) are 6.73% and psychological diseases
such as depression, anxiety, and personality disorders
are 6.65%. Those Nds that are associated with spinal
degenerative disease account for 10.52% while the
least common of all is intracranial tumors that account
2.61% of NDs38,39.
The prevalence of Nds in various regions of India
ranges from 967 to 4,070 with a mean of 2,394 per
100,000 individuals. These values indicate that over 30
million people are living with NDs in the 2nd largest
population of the world. The burden of common NDs in
India was 44% between 1990 and 2013 and it is
estimated that the burden of the NDs in India will
increase by 23% during the years 2013 to 202536,37. The
prevalence of common disorders such asstroke,
epilepsy, tremors, Parkinson's disease, and mental
retardation is not uniform across different regions of
the country due to varying social, economic, and
cultural features40,41.
Very limited data is available about the burden of NDs
in Kingdom of Saudi Arabia (KSA). Some studies have
reported the community based surveys. They ﬁgure
out 120.5 and 131/1000 population prevalence of Nds
in KSA10,42,43.A community based study was conducted
to investigate NDs in Saudi children that reported a
prevalence of 68.5/10,000 at pediatric level44.Recently,
one study has reported the spectrum of various
neurological disorders in KSA. Epilepsy and other
seizures with 37.71% were the most noted illnesses at
the tertiary care centers 28.

pressure. These factors are not uniform in all ethnic
groups of the world and are directly inﬂuenced by the
economic conditions of that particular region.The
South Asian countries are impregnated with such
factors resulting in high prevalence of hypertension.
Particularly, in Iran, some parts of China, and Pakistan,
the prevalence is higher than developed countries.
According tonational health survey conducted in 2000,
the prevalence of hypertension in Pakistan is 33% in
age group of 45 years or greater. Male individuals are
more prone to acquire hypertension than females
(34% vs 24%). The prevalence of hypertension
increases with age, after the age of 35 years the
chance of hypertension becomes 5.6 times greater
than that of the age group of fewer than 35 years.
Unawareness about the disorder is one of the serious
concerns that increase the chances of other related
complications. About 58% of hypertensive patients are
unaware of their hypertension46. Such unawareness
may increase the possible risk of complications in the
absence of proper medication.
Inan Iranian study conducted on a large population of
adults, the prevalence of hypertension was foundto be
42.7%.Unlike Pakistan, hypertension was more
prevalent in women than men (46.4% vs. 37.6%). It
was also noted that prevalence of hypertension was
directly associated with increased BMI, ethnicity, and
sedative life style. Comparatively low prevalence of
hypertension was observed in people who were fond of
taking black teaand smoking47,48.
Chinais the countrywhere the overall prevalence of
hypertension is less than that of Pakistan. About 26.6%
of 32.5% populations of Chinese of age less than 35
years are hypertensive but a comparison with the age
group of 45 years or greater shows that hypertension is
more prevalent in China36,37,49. Hypertension is more
prevalent in men than in women (29.2% vs 24.1%). In
those individuals with age 45 or greater, it ranges from
36.7% to 56.5% and it becomes 58.4% at the age 7074 years 5 0 , 5 1 .There is a higher prevalence of
hypertension in rural population than the urban52,53.
Meta-analysis and review of data from various
epidemiological studies in India reveal that the overall
prevalence of hypertension in India is 29.8%. Unlike
China, the prevalence is more in urban parts (33.8%)
than the rural parts (27.6%) of India. Awareness about
their hypertensive neurological status is lower in rural
population (25% are aware of hypertension) than the
urban (42%) 36,37,54.
In KSA, the prevalence is less than that of other Asian
countries including Pakistan. The prevalence of
hypertension in Saudia is 15.2% - 27.45% while those
that are at the borderline of hypertension are 40.6%.
Most of the hypertensive Saudi population

COMPARATIVE PREVALENCEOF SELECTED
NDs
HYPERTENSION
Hypertension, abnormally high blood pressure, also
indicated by a state of great psychological stress, is
one of the commonest NDs. Though, burden of
hypertension in the developing and developed
countries is almost equal but the prevalence varies
greatly around the world, for example, 3.4% Indian
menand 72.5% women in Poland suffer from this
illness45.Several factors such as social determinants
of health, e.g. income, education, and housing
aggravated be havioral risk factors play a key role in
the development of hypertension. Social issues such
as unemployment or fear of unemployment may
enhance stress level that in turn boot-up blood
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STROKE
Stroke or cerebral infarction is cell death in the brain
region caused by blockage of the blood vessel leading
to thebrain. A clot (ischemic stroke) may result in
blocking the arterial supply leading tohypoxia and
nutrients deﬁciency in the distal part of thebrain. The
consequences of stroke may be an everlasting
disability of an organ depending upon the affected part
of thebrain. It is the major contributor to the deaths
caused by various NDs and accounted about 87%
deaths out of 2.5 Million stroke patients in 200563. The
global incidence of stroke varies greatly in the different
parts of the world as it ranges from 41/ 100,000 in
Nigeria to 316/100,000 in Tanzania and 375/100,000
population in Iran64,65.
In Pakistan, it is also one of the serious health
concerns with the annual incidence of 250/100,000
population. About 350,000 cases of stroke are
expected to appear every year6670. The incidence of
stroke in Karachi has been reported to be 19.1% 71.A
hospital based study conducted in Islamabadhas
elucidated the risk factors for stroke among 281
registered patients. In the age group 56-71 years, the
highest frequency of these 4 risk factors was present 72.
The data of two studies from Iran indicate a rising
incidence of stroke over six years73. The prevalence
data of stroke in Iran is limited and according to some
available data obtained from southern Iran (Fars), the
prevalence is greater than Pakistan. It is found to be
375 reported cases of stroke per 100,000, also with
ahigh mortality rate of 20.5%65. Although this hospital
based data is not representative of thewhole
population of Iran but may be comparable to other
countries73.
The incidence of stroke in Chinese population (for
ages 45–74 years) is 205–584 per 100,000 individuals.
The major cause of stroke in Chinese population is
intracerebral hemorrhage that accounts for 27% to
51% of stroke cases in community-based studies and
17% to 30% cases in hospital based studies 74,75.While
other risk factors such hypertension (88%), smoking
(48%) and alcohol use (44%) respectively were also
reported among stroke survivors76. It has also been
reviewed in 2013 that the overall incidence of stroke
was 120.42 per 100,000 person-years and that the
incidence of stroke increased and mortality declined
over the time between 1982 and 200877. More recently,
age-standardized prevalence, incidence and mortality
rates 1114.8 per 100,000 people, 246.8 and 114.8 per
100,000 persons per year, respectively have also been
documented. China is a big country and
epidemiological data can be generalized for the whole
country. The highest annual incidence and mortality of
stroke in Northeast(365 and 159 per 100,000 personyears), then central areas (326 and 154 per 100,000
person-years), and the lowest incidence was in
S o u t h w e s t ( 1 5 4 p e r 1 0 0 , 0 0 0

(about 57.8%)is undiagnosed 28,55.
MIGRAINE
The manifestation of migraine is characterized by
recurrent episode of throbbing head pain that is
associated with other symptoms comprising of
vomiting and sensory sensitivities 56. The main cause of
the headache around the globe is migraine which is
identiﬁed amongst the 20 leading causes of disability
worldwide57. The most common disorder of the nervous
system is a headache, having several subtypes like
tension-type headache, migraine headache, and
cluster headache. Amongst these, the migraine is
abundant, predominant, disabling, and essentially
treatable, but still, under treated, unrecognized,
undiagnosed, and under-estimated. A genetic
predisposition is commonly seen in case of migraine
headache, but biological aspects have a deﬁnite role
that how the illness anguish those who suffer it. The
start of mechanism within the brain is reﬂective and
produces a release of pain-creating inﬂammation
inducing substances in the tertiary of blood vessels
and nerves of the brain 57. A close relationship exists
between stress and migraine attack, also in children. A
signiﬁcant psychiatric illness in migraine attack
suggests a paradigm of close interaction between
psychological and somatic aspects in pediatric
migraine 58.
In China, are headache disorders as prevalent as
elsewhere? The question is important regarding a
country of 1.3 billion people, but there is a very scanty
literature to ﬁgure out the reliable answer. In China, an
epidemiological study conducted in 2012, reported
9.3% prevalence of a migraine which is considerably
lower than the ﬁndings elsewhere, comparably nearby
Japan and Taiwan 59.
In India, the 1-year age-standardized prevalence of a
migraine was 25.2%, signiﬁcantly higher among
females than males and more among those from rural
areas than urban. In India, 25.2% is signiﬁcantly higher
than global 14.7% burden. According to Global Burdon
of Disease 2010 (GBD 2010) estimates, the global
prevalence of migraine is 14.7%, the third most
common disease in the world 60.
Using the random-effects model in Iran, the pooled
prevalence of a migraine was 14% (95% CI 12%
to17%) (Farhadi Z et al., 2016). In Saudi Arabia, a
study conducted by Al Jumah et al 2002, found a sharp
increase in the prevalence of a migraine (from~2%
to~9%) at ages 10 to 11 years for both genders. The
age-adjusted occurrence of a migraine in subjects
aged 6 to 15 years was 6.2%61 .
As far as Pakistan is concerned, there is no difference
between males and females affecting from migraine. A
migraine is also very communal, reported by over oneﬁfth (22.9%) while tension type headache (TTH) is by
far the most prevalent headache disorder (44.7%)62 .
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which have age younger than 30 years. This number of
epilepsy cases accounts about 10 percent of the
worldwide burden92. Mostly the people with age >30
years were reported with epilepsy while prevalence
ratio was less in the cohort of 40-59 years old89. Social
attitude of a society towards the affected ones and their
family consequences stigmatization and irremovable
hurdle in the remedial steps93.
In Iran, the prevalence of epilepsy is almost same as
that of the other developing countries. According to a
study conducted in Kerman, the prevalence was found
to be 7.87/1000 in both genders. In a house based
survey, 17.3% of patients had a family history of
epilepsy 94. Some studies indicate the positive attitude
and good knowledge of Iranian people for Epilepsy and
epileptic patients 95,96.
About 9 million Chinese people are devilling with
epilepsy and 0.4 million new cases are expected to
appear each year97,98.In China, the prevalence of
epilepsy is at the lowest range in the Asian countries
with a value 2.89/1000 people. Among the various
subtypes of seizures, the generalized seizures are
more common with aprevalence of 3.12/1000. These
seizures are more prevalent in males, rural and age
group of 10–19 years99,100.
Epidemiological data manifests that prevalence of
epilepsy in India and in high income countries is
comparable. Nearly 10-12 million Indians are living
with epilepsy which contributes to nearly one-sixth of
the global burden. The overall prevalence of epilepsy
in India has been estimated 3.0-11.9/1,000 with an
incidence of 0.2-0.6 per 1,000 population per year 101,102.
According to the available data, the prevalence of
epilepsy was found 6.54/1000 population in Saudi
Arabia103105.Stigmatization was noted as a severe social
outcome in the epileptic patients. It was reported that
about 78% of people refused to marry a person with
epilepsy not only in Saudi Arabia but it is a commonly
exercised practice all around the world106109.

Stroke prevalence in men was signiﬁcantly higher than
those in women in the age group of ≥40 years76.
Common disorders such as stroke, epilepsy,
Parkinson's disease and tremors have considerable
variations in the prevalence and incidence rates
across different regions of India41,78,79. The average
incidence of stroke each year is 145 per 100,000
populations and other study reports 27–42% portion of
Stroke among other major neurological disorders
41,80. That means about 1.8 million cases of stroke
appear each year out of total Indian population of about
1.2 billion.The mortality rate due to stroke out of these
patients is about 33%7981.
In KSA, studies conducted 3 decades ago indicate a
low incidence and prevalence of strokes compared to
the Western countries.It is because of the
predominance of the younger age groups in this
country 73,8284. In KSA, the incidence of stroke is lower
than that of Pakistan. The burden of stroke is not much
different from the range that is present globally and in
the other Asian countries85. Its value is slightly higher
than that prevailing in India. However, it has been
reported thatthe crude incidence of stroke in KSA was
29.8/100,000/year in the past decades8284 and at
pediatric level the burden of stroke was 27.1/100,000
of the pediatric population86. According to a community
based survey conducted in the Eastern Province of
KSA, the prevalence of stroke is 178/100,000
population 87 which does not differ much from the other
study that reported a prevalence 186/100,000
population88. All these variations in the data depict the
nation-wide epidemiological survey in this important
Arabian country.
EPILEPSY
Epilepsy, characterized by repeated episodes of
epileptic seizures due to abnormally excessive or
synchronous neuronal activity in the brain, is one of the
most commonly occurring NDs. Epilepsy is not only a
problem of the affected individual but also have a great
inﬂuence on the family and society. People suffering
from epilepsy with their families had to suffer from
humiliation and discrimination that decreases the
chances of sharing their disease condition and
receiving proper consultancy. About 50 million people
worldwide are suffering from epilepsy that accounts
about 1% of global burden of diseases. The worldwide
burden of epilepsy is about 5–10/1000 population.
A very limited set of data regarding the prevalence of
epilepsy in Pakistan is available. According to
available data, epilepsy is more prevalent in Pakistan
than other nearby Asian countries. The average
prevalence of this fatal disease is 9.99/1000
individuals and for the rural areas, the ﬁgure becomes
double (14.8/1000) than in urban areas
(7.4/1000)–8991.About 2 million people in Pakistan are
suffering from epilepsy most of epilepsy most of
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DEPRESSION
Depression is a condition that adversely inﬂuences the
normal activity of a healthy brain. The affected one also
manifests anxiety, loss of positive thoughts,lack of
interest in the routine life, negative feelings,and sense
o f w e l l -b e i n g . H o p e l e ssn e ss, re stl e ssn e ss,
worthlessness, irritability, anger and being guilty are
the most observed symptoms of a person with
depression. The affected life activities even can result
in ﬁnancial loss and death in the form of suicide. About
350 million people (5% of world's population) of all
ages worldwide have depression and about 800,000
people mostly of 15 to 29 years old, die annually due to
depression35,110,111.
In Pakistan, the available data indicate 34%
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prevalence of depression and anxiety and it is more
common among women 112,113. According to locally
reported data,depression is more prevalent in the rural
areas (66% in women and 25% in men) than in
urbanareas (25% in women and 10% in men)114,117. It
may be due to the poor economic conditions in the rural
areas that aggravate the situation. The prevalence of
depression in Pakistani population variesdue to
varying socioeconomic factors, children health, age
and geographic location throughout the country118,121.
According to various reports, the prevalence of
depression in Iran is 51.1%. Among these data, the
prevalence of severe depression symptoms (GDS Geriatric Depression Scale >10) is19.7%1 2 2 , 1 2 5 .
Prevalence of depression is remarkably high among
the elderly people, particularly among women. Social
factors and inactive or sedentary life style are
contributing to increase the prevalence with the
passage of time126,128.
Recent investigations indicate that around 100 million
Chinese are living with depression and living alone is a
signiﬁcant factor for increasing rate1 2 9 , 1 3 1 . The
prevalence of depression and depression associated
disorders ranges from 11.3% to 18.1%. It is also
observed that there is a high prevalence of depression
among elderly people, especially among medically
institutionalized individuals. The trend of medication
against depression is poor in the Chinese population,
only less than 1% of the patients receive treatment.
Most of the people with depression are unaware of
their illness and refuse to take any remedial steps–132136.
Modernization is contributing to elevate the depression
level in Chines people 137,138.
It is reported that 1 out of 20 Indians is suffering from
depression139. According to press reports about4.5%
population of India is somehow suffering from
depression140. In the remote areas, a large portion the
elderly ones is facing depression due to social and
ﬁnancial conditions141,144 and a large proportion of
population who suffers fromdepression remains
undiagnosed either due to poor understanding of the
associated factors or due to inefﬁcient screening and
treatment opportunities145,146. Majority of the family
members particularly mother of special child show
depressive symptoms147. Many studies have been
conducted to determine the prevalence of depression
and its association toother prevailing disorders such as
diabetes, cancer, cardiovascular disease and
AIDS 148,150. Among the young adults from a population
of Ranchi city of India, the prevalence from mild to
extremely severe depressive symptoms appeared
18.5%, anxiety 24.4%, and stress 20% 149,151. Compare
to then eighbours, in Indian population, all age groups;
elderly to youngster show signs of depression 141,152156.
In Saudi Arabia, the prevalence of depression is
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almost similar to that of Pakistan. The overall
prevalence is 39% but varies greatly in various regions
of Saudi Arabia. The prevalence of depression was
35.7% in Riyadh, the most populated city of Saudi
Arabia157,158. Other parts of this geographically large
country show varying values of depression among the
inhabitants at different levels. Abdelwahid et al.,
reported 12% depression at a tertiary care center in
Southeastern Saudi Arabia159. Depression as an after
effect of many diseases has been reported at an
alarming rate in this country. Post-stroke depression is
a common type of this illness and mostly observed in
the people of all age groups1 6 0 . Moreover, its
appearance as an associated factor to the other
diseases such as diabetes mellitus, cardiovascular
disorders, post-surgery consequences and cancer
cannot be ignored in the region 161,162. The education
quality is being adversely affected due the high
prevalence of depression among the students. A study
reports a 30.9% depression among the medical
students163,164. Other ﬁelds of education may have
similar tendency of this behavioral disorder. The school
going children are not out of reach of this
disorder165.The elderly Saudi people share a 39%
prevalence of depression and depict an alarming
situation in this peninsula166,168. Kingdom of Saudi
Arabia hosts a considerable population of foreigner
workers as a labor force. These people are also
suffering from depression due to unfavorable working
conditions and other social factors169.
PARKINSON'S DISEASE (PD)
More than 10 million peoples worldwide are living with
Parkinson's disease (PD). PD is characterized by
t r e m o r s , r i g i d i t y, m o v e m e n t a n d p o s t u r a l
abnormalities.Loss of dopaminergic neurons in
substantianigra pars compacta is considered as a
major cause of the diseases. The process of cell death
is greatly associated with aging, there fore the chance
of PD increases with the increasing age. It has been
indicated that a strong correlation exists between
prevalence of PDand aged populationin an area.
Peoplewith age of 80 years or older are 46 times more
likely to acquire PD than those of 40 years old170,171. As
PD predominantly affects older adults, worldwide
aging populations, especially in economically
developed countries, will increasingly need to develop
strategies to meet the health care needs of individuals
with PD. Information on the variation in the incidence of
PD between age groups and genders can be used to
effectively direct these strategies to appropriate
populations171.
About 450,000 people in Pakistan suffer from PD in a
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population of about 182 million that accounts about
219 individuals with PD in every 100,000 individuals. In
a study conducted in Sindh province, data obtained
from Agha Khan University Hospital, to evaluate
clinical spectrum of the disease, it is found that the
prevalence is more in males (63%) than in females
(37%) 172,173.Some of the hospital based data is
available regarding the prevalence of PD in Karachi
and Peshawar. The data show more prevalence in
male and in rural areas than female and in urban areas,
respectively172,174. Recently, a newspaper reported that
more than 600,000 people are living with PD in
Pakistan; perhaps we are unable to conﬁrm the source
of the information.
In Iran, the prevalence rate of PD is 285/100,000. More
prevalence is found in males than in female175. The ratio
of PD in male and female was 1.62 176,177. Sings of
depression appear in the patients suffering from PD
and aggravate the situation178
In China, the prevalence of PD is much lower than in
other Asian countries including Pakistan. There are
2/100,000 individuals and over 2.5 million chines have
PD.Males were found 25% more prone to have PD in
the later age than females179,180. An increasing trend in
the annual prevalence rates of PD from 2004 to 2011
has been reported181,182. Overall, the prevalence of this
disease appears to increase with age and there are
sex differences evident in the Chinese 130,183.
In India,the prevalence of PD is greater than that of
China but less than most of the other Asian countries.
The crude prevalence of PDin India varies from
6–53/100,00041. According to a community based
study conducted in Kolkata in 2006, the prevalence
found is 53/100,000 and the average annual incidence
rate is 5.71/100,000 per year184,185. In most of the
studies,it was found that prevalence rate was higher in
men than in women and this was attributed to
thelonger life expectancy of women186,187.
Among the population of Saudi Arabia, the incidence of
PD was reported at 4.5/100,000 person-years and
reported prevalence at 27-43/100,000 population and
it accounts the cause of dementia in around 7% of
Arabs42,188,189.

distribution of dementia due to Alzheimer's disease
(AD) was more common (60%) than vascular
dementia (30%)190,193.
Epidemiological data regarding the prevalence of AD is
lacking in Pakistan. Very limited data indicates the
presence and frequency of AD in elderly people and its
association with other diseases194,195.
The number of people with AD/dementia in Chinais
9.19 million with a prevalence of 2.6% among the
people of age group 65-69 years. A population of about
5.69 million effected by AD with an overall prevalence
of 1.6% according to a study conducted in 2010 196. The
prevalence of AD is higher in urban (2.29%) than in
rural population (1.67%) 197.The people of 65 years or 99.
In India, the prevalence of various types of dementia
and AD is less than that reported in theoverall
prevalence of dementia in Asia200.The prevalence in
the individuals with age 40 year or more is 0.43% while
in the individuals with age 65 years or more is 2.5%.
Women are more commonly affected by AD than men
with a female to male ratio of 1.58200,202.
CONCLUSIONS
Neurological disorders are the diseases of nervous
system that may consequence functional aberrations
such as depression, movement disorders, and
paralysis. Traditionally, policy makers and researchers
consider mortality statistics as the principal measure of
the seriousness of any disease. Mortality statistics
alone, however, under estimate the suffering caused
by diseases that may be nonfatal but causes
substantial disability throughout the life10,33. Many
neurological and psychiatric conditions belong in this
category. The absenteeism of some neurological
disorders from lists of leading causes of death has
contributed to their long-term neglect. When the
relative seriousness of diseases is assessed by time
lived with disability rather than by mortality, several
neurological disorders appear as leading causes of
suffering worldwide10,33 . WHO data suggest that
neurological and psychiatric disorders are an
important and growing cause of morbidity, mortality,
and disability203. The magnitude and burden of mental,
neurological, and behavioral disorders is huge,
affecting more than 450 million people globally.
According to the Global Burden of Disease Report,
33% of years lived with disability and 13% of disabilityadjusted life years (DALYs) are due to neurological and
psychiatric disorders, which account for four out of the
six leading causes of years lived with disability 11,33.

ALZHEIMER'S DISEASE/DEMENTIA
Dementia is a late onset important neurological
condition forth coming epidemic in our society that
asks for our urgent attention. Due to escalation in life
expectancy, the number of elderly people in our society
is increasing.The prevalence of dementia is projected
to much more higher than our expectation.As per
prevalence data from developing countries, dementia
in individuals more than 65 years of age or older was
more prevalent in Asia and Latin America than India
and sub-Saharan Africa (1-3%). Worldwide
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Unfortunately, the burden of these disorders in
developing countries remains largely unrecognized.
Moreover, the burden imposed by such chronic
neurological conditions in general can be
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expected to be particularly devastating in poor
populations. Major manifestation of an impact on the
poor includes loss of gainful employment, cost of
medications and need for other medical services can
particularly be devastating. In addition to health costs,
they frequently subjected to human rights violations,
stigmatization, and discrimination. Stigmatization and
discrimination further limit patients' access to
treatment. These disorders, therefore, require special
attention particularly in developing countries33,204.
In this review, we address the prevalence of commonly
reported neurological disorders in Pakistan in
comparison to Iran, India, China and Saudi Arabia. We

focused the prevalence of Migraine, Depression,
Hypertension, Alzheimer's disease (AD)/dementias,
epilepsy, Parkinson's disease (PD), and stroke.
Unfortunately, population-based data from these
countries on the epidemiology of these illnesses are
limited11,33. The available data predict that burden of
neurological disorders is rising due to increasing life
expectancy, urbanization of population and better
diagnostic facilities in this region10.The privation of
epidemiological data in Pakistan is manifested in the
health policy with little focus on neurological disorders.
The present review establishes a correlation of NDs
prevalence in Pakistan and in other Asian countries.

Table 1: Comparative prevalence of NDs
Disease

Worldwide

Pakistan

1.7–4

22.9

205

62

3.4-72.5

33

45

46

41-316

250

375

64

68

65

5-10

9.99

89.208

Migraine
Hypertension
Stroke
Epilepsy
Depression

Iran

China

India

KSA

14

9.3

25.2

5.1 - 7.1

59

60

61

42.7

22.7-40.7

29.8

15.2 - 40.6

47.48

50

54

55

205-284

145

178

207

41.80

87

7.87

2.89

3.0-11.9

6.54

89.92

94

99

101

106

5

34

51.1

11.3-18.1

18.5-21.7

39

111

112

123

133.180

141.151

157

(Farhadi Z et
al., 206)

Parkinson's
Disease

41-1903

219

285

2

53

27.43

170

172.173

176

179

41

188.189

Alzheimer's
Disease/
Dementia

1-5

N/A

N/A

2.6

2.5

196

201

209
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